Estradiol hemisuccinate/progesterone
Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation). It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection. The medication is available in Argentina and Paraguay.
Estradiol hemisuccinate (top) and progesterone (bottom) | |
| Combination of | |
|---|---|
| Estradiol hemisuccinate | Estrogen |
| Progesterone | Progestogen |
| Clinical data | |
| Trade names | Hosterona |
| Other names | EHS/P4 |
| Routes of administration | Intramuscular injection |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.